Gastrointestinal disease
Conditions
Interventions
Group 2:Remimazolam intravenous injection
Sponsors
Department of Anesthesia Surgery, Gansu Provincial People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. 18 years old = 92% when breathing air before operation; 180 mmg >= SBP >= 90 mmHg; 100 mmHg >= DBP >= 50 mmHg; 4.18 kg/m^2 <= BMI <= 28 kg/m^2; 5. Before the experiment, understand the nature, significance, possible benefits, possible inconvenience and potential risks of the experiment in detail, understand the research procedure and voluntarily sign a written informed consent.
Exclusion criteria
Exclusion criteria: 1. Requires complex endoscopic diagnosis and treatment techniques; 2. Patients who are judged to be difficult to manage the airway (modified Matheson classification IV); 3. Those who are allergic or contraindicated to benzodiazepines, opioids, propofol, propofol emulsion injection excipients; 4. Participated in other drug clinical trials as subjects in the past 3 months; 5. Patients who cannot obtain informed consent, or who are considered by the investigator to be inappropriate to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of intraoperative adverse events;Anesthesia Recovery Time; | — |
Countries
China
Contacts
Public ContactYan Wenjun
Department of Anesthesia Surgery, Gansu Provincial People's Hospital
Outcome results
None listed